CIAS
PACB icon

Capital Investment Advisory Services’s Pacific Biosciences PACB Stock Holding History

Capital Investment Advisory Services’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100
Closed -$1K – 1441
2019
Q2 		$1K Hold
100
– – ﹤0.01% 1351
2019
Q1 		$1K Hold
100
– – ﹤0.01% 1164
2018
Q4 		$1K Buy
+100
New +$634 ﹤0.01% 1141

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
KLCMU
Kite Lake Capital Management (UK) London, United Kingdom $290M AUM 183.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Capital Investment Advisory Services's PACB Position: Q3 2019 in Review

Capital Investment Advisory Services sold out of Pacific Biosciences (PACB) in Q3 2019, closing a stake of 100 shares — an estimated $1K sold.

Capital Investment Advisory Services first reported a position in PACB in Q4 2018 and held it in 3 quarters. The position peaked at $1K in Q2 2019. 148 funds tracked by Wall St. Rank hold PACB as of Q3 2019.

  • Capital Investment Advisory Services reported no remaining Pacific Biosciences position as of Q3 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 100 Pacific Biosciences shares in Q3 2019, an estimated $1K.
  • Capital Investment Advisory Services first reported a position in Pacific Biosciences in Q4 2018 and held it in 3 quarters.
  • Capital Investment Advisory Services's Pacific Biosciences position peaked at $1K in Q2 2019.
  • 148 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2019.

Based on Capital Investment Advisory Services's 13F filing for Q3 2019, filed 17 Oct 2019.